We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Argan Worth Buying as Growth Surges but Valuation Stays Elevated?
Read MoreHide Full Article
Key Takeaways
Argan's revenues rose 56.5% as adjusted EBITDA climbed to $126.5 million in fiscal 2027's first half.
AGX's $2.5 billion backlog provides visibility, with 48% expected to convert to revenues within 12 months.
Margin pressure and uncertain awards weigh on AGX, which trades at a premium 31.1X forward earnings.
Argan, Inc. (AGX - Free Report) is producing rapid revenue and earnings growth, but its valuation still assumes substantial execution. Investors must decide whether the infrastructure opportunity and earnings momentum justify paying a premium for a business whose project timing and margins can vary.
Backlog provides multi-year visibility and power infrastructure demand remains healthy. Margin normalization, award timing and a concentrated project mix can still produce uneven results.
Argan’s Growth Engine Remains Powerful
Revenues increased 56.5% year over year to $674.9 million in the first six months of fiscal 2027. Adjusted EBITDA rose to $126.5 million from $70 million as construction activity expanded.
The Zacks Consensus Estimate calls for fiscal 2027 sales growth of 45.4% and earnings growth of 38%. Argan ended July with $1.03 billion of cash, cash equivalents and investments, $440.4 million of net liquidity and no debt, supporting ongoing operations and growth investments.
AGX Backlog Supports Multi-Year Revenues
Backlog totaled $2.5 billion as of July 31, 2026, compared with $2.9 billion at fiscal 2026 year-end. Approximately 80% was tied to natural gas, 11% to renewable work and 8% to Industrial projects.
About 48% of remaining performance obligations are expected to convert to revenues over the next 12 months, with substantially all the remainder expected in the following 12 to 24 months. Management expects a handful of project additions over the next seven to 15 months, but major-award timing remains uncertain.
Argan’s Execution Risks Are Becoming Clearer
Execution is the main counterweight to that visibility. Consolidated gross margin declined from 25% in the fourth quarter of fiscal 2026 to 21% in the first quarter and 19.3% in the second quarter of fiscal 2027. Industrial gross margin fell to 7.3%, and management expects it to remain below historical norms for another quarter or two.
Project owners control milestones involving permits, financing, gas access and equipment, while Argan is staffing for 10 to 12 simultaneous projects. Quanta Services, Inc. (PWR - Free Report) has cited data centers, manufacturing reshoring and electrification as electric infrastructure demand drivers. Primoris Services Corporation (PRIM - Free Report) , which serves utility, energy and renewable infrastructure markets, reported $13.9 billion of total backlog as of June 30, 2026.
AGX Still Trades at a Premium Valuation
AGX trades at 33.1X trailing earnings and 31.1X forward earnings. Its trailing multiple exceeds the Zacks sub-industry’s 19.3X, the Zacks Construction sector’s 21.8X and Argan’s five-year median of 20.3X.
The premium matters while Industrial margins remain soft and new-award timing is uncertain. Sustained earnings delivery is therefore important, with less valuation room for slower awards or execution slippage.
Argan’s Signals Favor Growth Over Value
The bottom line is that AGX’s growth signals are favorable, but value remains the weaker part of the setup. The stock carries a Zacks Rank #2 (Buy), while its Growth Score of A and Momentum Score of A indicate favorable growth and momentum characteristics over the shorter-term horizon. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
AGX also has a VGM Score of A, which combines value, growth and momentum factors, alongside a Value Score of D. That mix supports the growth and momentum profile but keeps valuation central to the decision. Investors still need to weigh earnings momentum against margin, project-timing and valuation risks.
View the Zacks #1 Rank List
Image: Bigstock
Is Argan Worth Buying as Growth Surges but Valuation Stays Elevated?
Key Takeaways
Argan, Inc. (AGX - Free Report) is producing rapid revenue and earnings growth, but its valuation still assumes substantial execution. Investors must decide whether the infrastructure opportunity and earnings momentum justify paying a premium for a business whose project timing and margins can vary.
Backlog provides multi-year visibility and power infrastructure demand remains healthy. Margin normalization, award timing and a concentrated project mix can still produce uneven results.
Argan’s Growth Engine Remains Powerful
Revenues increased 56.5% year over year to $674.9 million in the first six months of fiscal 2027. Adjusted EBITDA rose to $126.5 million from $70 million as construction activity expanded.
Argan, Inc. Price and Consensus
Argan, Inc. price-consensus-chart | Argan, Inc. Quote
The Zacks Consensus Estimate calls for fiscal 2027 sales growth of 45.4% and earnings growth of 38%. Argan ended July with $1.03 billion of cash, cash equivalents and investments, $440.4 million of net liquidity and no debt, supporting ongoing operations and growth investments.
AGX Backlog Supports Multi-Year Revenues
Backlog totaled $2.5 billion as of July 31, 2026, compared with $2.9 billion at fiscal 2026 year-end. Approximately 80% was tied to natural gas, 11% to renewable work and 8% to Industrial projects.
About 48% of remaining performance obligations are expected to convert to revenues over the next 12 months, with substantially all the remainder expected in the following 12 to 24 months. Management expects a handful of project additions over the next seven to 15 months, but major-award timing remains uncertain.
Argan’s Execution Risks Are Becoming Clearer
Execution is the main counterweight to that visibility. Consolidated gross margin declined from 25% in the fourth quarter of fiscal 2026 to 21% in the first quarter and 19.3% in the second quarter of fiscal 2027. Industrial gross margin fell to 7.3%, and management expects it to remain below historical norms for another quarter or two.
Project owners control milestones involving permits, financing, gas access and equipment, while Argan is staffing for 10 to 12 simultaneous projects. Quanta Services, Inc. (PWR - Free Report) has cited data centers, manufacturing reshoring and electrification as electric infrastructure demand drivers. Primoris Services Corporation (PRIM - Free Report) , which serves utility, energy and renewable infrastructure markets, reported $13.9 billion of total backlog as of June 30, 2026.
AGX Still Trades at a Premium Valuation
AGX trades at 33.1X trailing earnings and 31.1X forward earnings. Its trailing multiple exceeds the Zacks sub-industry’s 19.3X, the Zacks Construction sector’s 21.8X and Argan’s five-year median of 20.3X.
The premium matters while Industrial margins remain soft and new-award timing is uncertain. Sustained earnings delivery is therefore important, with less valuation room for slower awards or execution slippage.
Argan’s Signals Favor Growth Over Value
The bottom line is that AGX’s growth signals are favorable, but value remains the weaker part of the setup. The stock carries a Zacks Rank #2 (Buy), while its Growth Score of A and Momentum Score of A indicate favorable growth and momentum characteristics over the shorter-term horizon. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
AGX also has a VGM Score of A, which combines value, growth and momentum factors, alongside a Value Score of D. That mix supports the growth and momentum profile but keeps valuation central to the decision. Investors still need to weigh earnings momentum against margin, project-timing and valuation risks.